BCMA导向治疗,骨髓瘤工具箱中的新疗法,以及如何使用它们
Matthew James Rees1, Shaji Kumar1
1Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Leukemia & lymphoma
|February 14, 2024
概括
针对B细胞成熟抗原 (BCMA) 的新免疫疗法为复发性耐火性多发性髓瘤 (RRMM) 提供了希望. 这篇评论探讨了BCMA的研究.
科学领域:
- 瘤学和免疫学
- 血液学 血液学 血液学
- 药物开发 药物开发
背景情况:
- 复发性耐火性多发性骨髓瘤 (RRMM) 对有效疗法存在重大未满足的需求.
- B细胞成熟抗原 (BCMA) 是多发性骨髓瘤的关键点,因为它在血细胞存活和健康组织上受限的表达中的作用.
- 目前的治疗策略有限,需要新的方法.
研究的目的:
- 审查BCMA在多发性骨髓瘤 (MM) 发病过程中的生物学作用.
- 分析已批准和新兴的RRMM的BCMA导向免疫疗法.
- 讨论这些新型药物的最佳测序策略.
主要方法:
- 关于多发性骨髓瘤中BCMA生物学和治疗点的文献综述.
- 对BCMA定向抗体-药物合物 (ADC),CAR T细胞和双特异性抗体的临床数据的分析.
- 对每个治疗类别的疗效,安全性和后勤考虑的评估.
主要成果:
- BCMA是MM治疗的验证目标.
- ADCs显示适度有效性,但受到毒性限制.
- 卡尔-T细胞提供高效率,但面临着可访问性挑战.
- 双特异性抗体提供了有效性和耐受性的平衡,感染风险是令人担忧的.
结论:
- 针对BCMA的免疫疗法代表了RRMM治疗的重大进展.
- 每一种治疗方式 (ADC,CAR T细胞,双特异性抗体) 都具有独特的优点和局限性.
- 优化治疗顺序对于最大限度地提高RRMM患者的治疗结果至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K